Market revenue in 2023 | USD 2,311.2 million |
Market revenue in 2030 | USD 3,904.4 million |
Growth rate | 7.8% (CAGR from 2023 to 2030) |
Largest segment | In vitro fertilization (ivf) |
Fastest growing segment | Artificial Insemination |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In Vitro Fertilization (IVF), Artificial Insemination |
Key market players worldwide | Micromem Technologies Inc, CooperSurgical, FUJIFILM Holdings Corp, Vitrolife AB ADR, European Sperm Bank, Merck KGaA, Ferring, Bloom IVF |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to assisted reproductive technology market will help companies and investors design strategic landscapes.
In vitro fertilization (ivf) was the largest segment with a revenue share of 92.46% in 2023. Horizon Databook has segmented the China assisted reproductive technology market based on in vitro fertilization (ivf), artificial insemination covering the revenue growth of each sub-segment from 2018 to 2030.
In addition, increasing demand for IVF treatments in China is expected to boost the demand for clinics located abroad, such as Virtus Health and Monash IVF Group (Australia) and Superior A.R.T. (Thailand), where 30% to 40% of visitors are from China.
Moreover, clinics such as Superior A.R.T. have appointed Chinese-speaking staff owing to the increase in the inflow of Chinese patients. Presence of strict regulatory policies and increasing need for more doctors & embryologists are among the major factors that have created a gap in the market.
Couples with financial means are flying to the U.S., Thailand, Australia, and Vietnam for IVF treatments. Surrogacy and gender selection are banned in China, which has led to an increase in the number of people visiting Australia and the U.S. where these laws are favorable.
Horizon Databook provides a detailed overview of country-level data and insights on the China assisted reproductive technology market , including forecasts for subscribers. This country databook contains high-level insights into China assisted reproductive technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account